OncLive

Education ▼

Register | Login

Conference Coverage

Attend An Event

State of the Science Summit

Regional Seminar Series

PER Conferences

OS by PS in Metastatic Pancreatic Cancer Treatment- Data From an Exploratory Subgroup Analysis

SPECIALTY TOPICS

CURRENTLY VIEWING
Hematologic Oncology

Multiple Myeloma

Immuno-Oncology News

Gynecologic Oncology

Gastrointestinal Cancer

Colorectal Cancer

Prostate Cancer

Neoadjuvant HER2+

Hematologic Oncology

Expert Discusses Evolution, Impact of Interferon in MPNs

Expert Discusses Evolution, Impact of Interferon in MPNs

Srdan Verstovsek, MD, PhD, discusses the use of interferon in rare blood diseases.
Read More >>

OncFellows Forum

FDA Grants Ivosidenib Priority Review for Frontline IDH1+ AML

Mesa Explores Role of Interferon in Evolving MPN Treatment Paradigm

FDA Grants Polatuzumab Vedotin Priority Review for DLBCL

Consistent Findings Validate Viability of TKI Discontinuation in CML

Novel AML Strategies Aim to Restore Regulatory Gene Functions

View More Stories >>

top border

View Conference Coverage

2019 Genitourinary Cancers Symposium

2019 Transplantation and Cellular Therapy Meetings

2019 Winter Lung Cancer Conference

2019 SGO Winter Meeting

2019 Gastrointestinal Cancers Symposium

Dr. Kambhampati on Challenges in CLL

Dr. Kambhampati on Challenges in CLL

Dr. Berdeja on Maintenance Therapy in Multiple Myeloma

Dr. Berdeja on Maintenance Therapy in Multiple Myeloma

Dr. Gordon Discusses Use of Checkpoint Inhibitors in Hodgkin Lymphoma

Dr. Gordon Discusses Use of Checkpoint Inhibitors in Hodgkin Lymphoma

Dr. Valent on Ongoing Research With Immunotherapy in Multiple Myeloma

Dr. Verstovsek on Benefit of Ruxolitinib in Polycythemia Vera

Dr. Shah on Investigational Agents in CML

Dr. Kaplan on the Phase III ECHELON-1 Trial in Hodgkin Lymphoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

The Future of ITP Treatment

The Future of ITP Treatment

Rituximab and Salvage Therapies for Patients With ITP

Rituximab and Salvage Therapies for Patients With ITP

Resistance Mechanisms in AML and Treatment Decisions

Resistance Mechanisms in AML and Treatment Decisions

Quizartinib for FLT3-Mutated AML

Blinatumomab for Patients with MRD-Positive ALL

Monitoring for Relapse in Acute Lymphoblastic Leukemia

Time Points in the Assessment of MRD

OncLive houses thousands of videos that provide updates and information.
See more Videos

$Identifying Unmet Needs in Relapsed/Refractory MCL$

Identifying Unmet Needs in Relapsed/Refractory MCL

Differentiating BTK Inhibitor Mechanisms of Action in MCL

Differentiating BTK Inhibitor Mechanisms of Action in MCL

MCL: Differences in Trial Design Between BTK Inhibitors

MCL: Differences in Trial Design Between BTK Inhibitors

Personal Insight Into Ibrutinib Use in Mantle Cell Lymphoma

The Future of AML Therapy: Cause for Optimism

IDH Inhibitors in AML Therapy

$Treatment Options for Relapsed/Refractory AML$

OncLive houses thousands of videos that provide updates and information.
See more Videos

top border

Featured Programs

Therapeutic Inhibition of XPO1-Mediated Nucleocytoplasmic Transport With SINE Technology

Therapeutic Inhibition of XPO1-Mediated Nucleocytoplasmic Transport With SINE Technology

Cancer is a complex disease characterized by uncontrolled cell growth and metastatic dissemination of tumor cells. View Now

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma. View Now

Featured Video

Novel Combination Approaches for Metastatic Kidney Cancer

Novel Combination Approaches for Metastatic Kidney Cancer

Brian Rini, MD, and David F. McDermott, MD, discuss novel combination approaches for patients with metastatic renal cell carcinoma. View now

FDA Approvals in Myeloma and aTTP, Priority Review Designations in RCC and HNSCC, and More

Gina Columbus highlights the latest news in oncology in this week's OncLive News Network.

OncLive State of the Science Summit

OncLive SAP

FDA Approvals in Myeloma and aTTP, Priority Review Designations in RCC and HNSCC, and More

Trending Now

Novel CLL Regimens Show Promising Efficacy

FDA Approves Adjuvant Pembrolizumab in Stage III Melanoma

FDA Grants Pembrolizumab Priority Review for Advanced SCLC

FDA Grants Entrectinib Priority Review for NTRK+ Tumors and ROS1+ NSCLC

Covering Every Angle of Oncology Practice. Click a cover below, to view more.

Publication Bottom Border

Dermatologists in Cancer Care®

Milestones In Medicine

Rapid Reviews in Oncology®

Urologists in Cancer Care

Oncology Business News

Contemporary Radiation Oncology

Oncology Nursing News

Oncology Fellows

Precision Medicine in Oncology

Invited Presentations

Oncology Treatment Pathways®

CURE Rare Cancers-Summer 2017 Issue

HEAL Summer 2017

Extraordinary Healers Vol. 11

Border Publication

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Oncology Nursing News
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedOnc

OncLive Resources

Articles
Blogs
Conference Coverage
OncLive TV
Peer Exchange
Publications
Specialties
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Forgot Password
Press Releases
Privacy Policy
Terms & Conditions

iTunes

YouTube

Google Plus

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-939-0221

Copyright OncLive 2006-2018
Intellisphere, LLC. All Rights Reserved.

x